Regeneron Pharmaceuticals, Inc.
Methods of assessing antibody-drug conjugates

Last updated:

Abstract:

The present disclosure provides methods of assessing DAR of ADC products that provide advantages over known methods. Specifically, methods of the disclosure can be used in high-throughput applications and/or without having to dilute ADC samples during the assessment.

Status:
Grant
Type:

Utility

Filling date:

5 Sep 2018

Issue date:

13 Apr 2021